137 related articles for article (PubMed ID: 11045892)
1. In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.
Sunkara G; Deruiter J; Clark CR; Kompella UB
J Pharm Pharmacol; 2000 Sep; 52(9):1113-22. PubMed ID: 11045892
[TBL] [Abstract][Full Text] [Related]
2. Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.
Sunkara G; Ayalasomayajula SP; Rao CS; Vennerstrom JL; DeRuiter J; Kompella UB
J Pharm Pharmacol; 2004 Mar; 56(3):351-8. PubMed ID: 15025860
[TBL] [Abstract][Full Text] [Related]
3. Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.
Sunkara G; Ayalasomayajula SP; DeRuiter J; Kompella UB
Brain Res Bull; 2010 Feb; 81(2-3):327-32. PubMed ID: 19761819
[TBL] [Abstract][Full Text] [Related]
4. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Vooturi SK; Kadam RS; Kompella UB
Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
[TBL] [Abstract][Full Text] [Related]
5. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
6. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
Chien DS; Tang-Liu DD; Woodward DF
J Pharm Sci; 1997 Oct; 86(10):1180-6. PubMed ID: 9344177
[TBL] [Abstract][Full Text] [Related]
7. A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.
Aukunuru JV; Sunkara G; Ayalasomayajula SP; DeRuiter J; Clark RC; Kompella UB
Pharm Res; 2002 Mar; 19(3):278-85. PubMed ID: 11934234
[TBL] [Abstract][Full Text] [Related]
8. In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye.
Babiole M; Wilhelm F; Schoch C
J Ocul Pharmacol Ther; 2001 Apr; 17(2):159-72. PubMed ID: 11324983
[TBL] [Abstract][Full Text] [Related]
9. On the prodrug potential of novel aldose reductase inhibitors with diphenylmethyleneaminooxycarboxylic acid structure.
Rakowitz D; Matuszczak B; Gritsch S; Hofbauer P; Krassnigg A; Costantino L
Eur J Pharm Sci; 2002 Feb; 15(1):11-20. PubMed ID: 11803127
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs of 5-iodo-2'-deoxyuridine for enhanced ocular transport.
Narurkar MM; Mitra AK
Pharm Res; 1989 Oct; 6(10):887-91. PubMed ID: 2608631
[TBL] [Abstract][Full Text] [Related]
11. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
Bito LZ; Baroody RA
Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
[TBL] [Abstract][Full Text] [Related]
12. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
Tirucherai GS; Dias C; Mitra AK
J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
[TBL] [Abstract][Full Text] [Related]
13. Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.
Cheng-Bennett A; Chan MF; Chen G; Gac T; Garst ME; Gluchowski C; Kaplan LJ; Protzman CE; Roof MB; Sachs G
Br J Ophthalmol; 1994 Jul; 78(7):560-7. PubMed ID: 7918269
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
[TBL] [Abstract][Full Text] [Related]
15. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs.
Dias CS; Anand BS; Mitra AK
J Pharm Sci; 2002 Mar; 91(3):660-8. PubMed ID: 11920751
[TBL] [Abstract][Full Text] [Related]
16. Intraocular availability of topically applied mycophenolate mofetil in rabbits.
Knapp S; Bertelmann E; Hartmann C; Keipert S; Pleyer U
J Ocul Pharmacol Ther; 2003 Apr; 19(2):181-92. PubMed ID: 12804063
[TBL] [Abstract][Full Text] [Related]
17. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
Tirucherai GS; Mitra AK
AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
20. Esterase activities in adult rabbit eyes.
Lee VH
J Pharm Sci; 1983 Mar; 72(3):239-44. PubMed ID: 6842375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
